HIV-1 subtype A gag variability and epitope evolution by Abidi, Syed Hani et al.
eCommons@AKU
Section of Urology Department of Surgery
January 2014












Follow this and additional works at: http://ecommons.aku.edu/pakistan_fhs_mc_surg_urol
Part of the Surgery Commons, and the Urology Commons
Recommended Citation
Abidi, S. H., Kalish, M. L., Abbas, F., Rowland-Jones, S., Ali, S. (2014). HIV-1 subtype A Gag variability and epitope evolution.. PLoS
ONE, 9(6), 1-9.
Available at: http://ecommons.aku.edu/pakistan_fhs_mc_surg_urol/16
HIV-1 Subtype A Gag Variability and Epitope Evolution
Syed Hani Abidi1, Marcia L. Kalish2, Farhat Abbas3, Sarah Rowland-Jones4, Syed Ali1*
1Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan, 2 Vanderbilt Institute of Global health, Vanderbilt University, Nashville,
Tennessee, United States of America, 3Department of Surgery, Aga Khan University, Karachi, Pakistan, 4Nuffield Department of Medicine, University of Oxford, Oxford,
United Kingdom
Abstract
Objective: The aim of this study was to examine the course of time-dependent evolution of HIV-1 subtype A on a global
level, especially with respect to the dynamics of immunogenic HIV gag epitopes.
Methods: We used a total of 1,893 HIV-1 subtype A gag sequences representing a timeline from 1985 through 2010, and 19
different countries in Africa, Europe and Asia. The phylogenetic relationship of subtype A gag and its epidemic dynamics
was analysed through a Maximum Likelihood tree and Bayesian Skyline plot, genomic variability was measured in terms of
GRA substitutions and Shannon entropy, and the time-dependent evolution of HIV subtype A gag epitopes was examined.
Finally, to confirm observations on globally reported HIV subtype A sequences, we analysed the gag epitope data from our
Kenyan, Pakistani, and Afghan cohorts, where both cohort-specific gene epitope variability and HLA restriction profiles of
gag epitopes were examined.
Results: The most recent common ancestor of the HIV subtype A epidemic was estimated to be 195661. A period of
exponential growth began about 1980 and lasted for approximately 7 years, stabilized for 15 years, declined for 2–3 years,
then stabilized again from about 2004. During the course of evolution, a gradual increase in genomic variability was
observed that peaked in 2005–2010. We observed that the number of point mutations and novel epitopes in gag also
peaked concurrently during 2005–2010.
Conclusion: It appears that as the HIV subtype A epidemic spread globally, changing population immunogenetic pressures
may have played a role in steering immune-evolution of this subtype in new directions. This trend is apparent in the
genomic variability and epitope diversity of HIV-1 subtype A gag sequences.
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Introduction
Under selection pressures from host immunity, human immu-
nodeficiency virus type 1 (HIV-1) rapidly mutates, which allows
the amplification of escape mutations that enables the virus to
evade the host’s immune response [1–3]. Sequences of HIV-1
subtype A that were first deposited in the Los Alamos National
Laboratory (LANL) HIV Sequence Database were of African
origin, from mid-80s. In subsequent years, as subtype A viruses
were disseminated globally, sequences from different parts of
world were made available in the LANL database. In the past few
decades, HIV-1 subtype A has established itself in certain regions
of the world including Kenya, Uganda, Japan, Azerbaijan,
Belgium, Botswana, Belarus, Congo, and recently, Afghanistan
and Pakistan (http://www.hiv.lanl.gov/) [4,5]. Analysis of the
evolutionary patterns of a virus in the context of its host
populations sheds light on the selection pressures on viruses that
are associated with specific host immune milieus [6,7]. This type of
information is useful in designing vaccines and drugs against the
virus.
In the current study, taking into account the sequences from
years 1985 to 2010, we have analysed the divergence and
evolution of HIV gag. We focus on both time-dependent as well as
cohort-specific evolution of the HIV-1 subtype A gag gene, and
present an analysis of evolutionary dynamics of HIV-1 subtype A
on a global level, especially with respect to the evolution of gag
epitopes.
Methodology
HIV-1 Subtype A Sequences
A total of 1,893 HIV-1 subtype A gag (spanning the p24 and
p2p7p1p6 gene regions) DNA sequences from 19 countries
(Rwanda, Kenya, Uganda, Sweden, Cyprus, Democratic Republic
of Congo, Belarus, Tanzania, Russia, China, Ukraine, Italy,
Australia, South Africa, Pakistan, Afghanistan, Spain, Zambia,
Cameroon) were included in this study (Table S1). These
sequences were downloaded from the HIV Los Alamos National
Laboratory (LANL) Database (http://www.hiv.lanl.gov/). Out of
these 1,893, a total of 94 sequences (19 Kenyan, 60 Pakistani and
15 Afghan) were from our previously studied cohorts [4,8–10].
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(Accession numbers: Kenyan cohort sequences: GU245698,
GU245706, GU245710, GU245712, GU245713-15, GU245720,
GU245726-27, GU245734, GU245736-37, GU245742-43,
GU245748-50, GU245758. Pakistani cohort sequences:
GU376767, GU376770, GU376772-74, GU376776-79,
GU376781, GU376783-85, GU376788-91, JF804693,
JF804697-21, JF804723-26, JF804730-37, JF804739-41,
JF804743-44. Afghan cohort sequences: JF808139,
JF808141, JF808144, JF808148, JF808151, JF808154, JF808156,
JF808159, JF808163-65, JF808168-70, JF808172). The p24 and
p2p7p1p6 region of gag was selected because the greatest number
of sequences - both in terms of countries and years - were available
for this region.
HLA analysis of samples from Kenyan, Pakistani and
Afghan cohort
Patient blood samples from our previously published cohorts in
Kenya, Pakistan, and Afghanistan were collected after obtaining
written informed consent. Ethical approval for this study was
obtained from the Ethical Review Committee, Aga Khan
University, Karachi, Pakistan. Using DNA samples from 94
Kenyan, Pakistani and Afghan patients, exons 2 and 3 of HLA
class-I loci HLA-A, -B, and -C were amplified by PCR, based on
the protocol described by Bettinotti, et al. [11,12]. Approximately a
1 kb DNA fragment was amplified for each locus using exon-
specific primers. Three different pairs of primers (HLA-A locus:
59TTCTCCCCAGACGCCGAGGATGGCC39, and 59TGTT
GGTCCCAATTGTCTCCCCTC39; HLA-B locus: 59AC-
CCACCCGGACTCAGAATCTCCT39, 59GGAGGCCATCC
CCGGCGACCTAT39, and 59GGAGGCCATCCCCGGC-
GATCTAT39; HLA-C locus: 59GAGAAGCCAATCAGCG
TCTCCGCA39, and 59GGAGATGGGGAAGGCTCCCCAC
T39) were used for amplification of the region extending from
50-untranslated region (50-UTR) to the third exon of the HLA
gene locus on human chromosome six [11,12]. The PCR products
obtained were commercially sequenced by Macrogen Inc., Korea,
using primers for exons 2 (59CACTCCATGAGGTATTTC39)
and 3 (59GGCCAGGGTCTCACA39). The same pairs of primers
were used for all three loci, HLA-A, -B, -C. These sequences were
used to assign HLA types employing the BLAST search option,
available on the ImMunoGeneTics/Human Leukocyte Antige-
n(IMGT/HLA) database [13].
Collection and year-wise grouping of HIV-I Subtype A
sequences
From a total of 1,893 sequences, the oldest HIV-1 subtype A
gag sequence was from 1985 (Uganda), while the most recent
sequences were from 2010. These sequences were divided into five
groups, all but one representing a 5-year block of sequences; the
last block, 2005–2010, covered 6 years (inclusive of years 2005 and
2010). These groups were: 1985–1990, 1990–1995, 1995–2000,
2000–2005, and 2005–2010, comprising 133, 131, 1262, 198, and
169 sequences, respectively. All sequences were aligned using
MEGA5 software [14] and trimmed to a length of 447 bp. Unless
stated otherwise, for all analyses performed, the same grouping of
sequences was maintained.
Phylogenetic Analysis
Evolutionary relationships among the HIV-1 subtype A
sequences were analysed using a Maximum likelihood (ML) tree,
constructed with 1,893 subtype A gag sequences using MEGA5
[14]. For the ML tree, the following parameters were used:
substitution model – GTR; rates among sites – Gamma distributed
with Invariant sites (G+I); number of discrete gamma categories –
5 (default value); ML heuristic method – Nearest-Neighbor-
Interchange (NNI); initial tree for ML – NJ/BioNJ; test of
phylogeny – bootstap (100 replicates). For this analysis, the SIVcpz
gag sequence from 1988 (Accession number: X52154) was used as
outgroup to root the tree. The ML tree was refined using FigTree
v1.3.1 (http://tree.bio.ed.ac.uk/software/figtree/) software. The
software artificially compresses the tree to fit in large number of
sequences.
Effective population size and time of the most recent
common ancestor (tMRCA)
A Bayesian Markov Chain Monte Carlo (MCMC) inference
was applied to estimate the effective population size and tMRCA
of HIV subtype A, using BEAST v1.7.4 software [15]. For this
analysis, a total of 113 sequences from different countries from
1985 to 2010 were used. Sequences were selected using the
approach described by Novitsky, et al. [6], where a limit was set to
5–6 sequences per country and year-groups. If 5 or less sequences
were represented in a country all of them were included in the
analysis. Bayesian analysis was performed using the following
parameters: uncorrelated lognormal relaxed molecular clock
model [16], general time-reversible (GTR) nucleotide substitution
model, estimated base frequencies, and gamma distribution model
for heterogeneity among nucleotide sites. The analysis was
performed using demographic models of constant population size
and Bayesian skyline plot [17]. The MCMC chain length was set
at 26108, which gave an effective sample size (ESS) of .200.
MCMC sample analysis and Bayesian skyline plot construction
were performed using Tracer v1.7.4. In a separate experiment, in
order to control the effect of high GRA substitutions on effective
population size and tMRCA, all sequences with high GRA
substitutions (mostly Afghan and Pakistani sequences) were
removed and the Bayesian analysis was performed again.
Time-dependent genomic variability
In order to evaluate time-dependent changes in HIV subtype A
genomic variability, GRA substitutions and Shannon entropy
analyses were performed. The Shannon entropy of subtype A gag
gene sequences from the five different year-groups was calculated
with as well as without the sequences from our three cohorts, using
an online tool available at the Los Alamos National Laboratory
(LANL) HIV Sequence Database: http://www.hiv.lanl.gov/
content/ sequence/ENTROPY/entropy_one.html.
GRA substitution analysis of the HIV sequences was performed
using Hypermut (both 2.0 and old versions) tool available at the
LANL HIV Sequence Database (http://www.hiv.lanl.gov/
content/sequence/HYPERMUT/hypermut.html) [18]. For this
analysis, HIV subtype A reference sequences from years 1985,
1992, and 2003 were retrieved from LANL HIV Sequence
Database and were used as follows: 1985 sequence was used for
the year group 1985–1990, 1992 sequence for year-groups 1990–
1995 and 1995–2000, and 2003 sequence for 2000–2005 and
2005–2010 [19]. Since a reference sequence for year 2005 through
2010 was not available in the LANL database, the 2003 reference
sequence was used for 2000–2005 as well as for 2005–2010 block.
The values for each step (GRA substitutions and Shannon
entropy) were entered into the GraphPad software to determine the
mean for each group, while statistical significance between year-
wise groups was calculated using one-way ANOVA with Tukey’s
multiple comparison test, using GraphPad software.
HIV-1 Subtype A Epitope Evolution
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Prediction of CTL epitopes and HLA restriction
Consensus gag gene sequences for each year-group were
translated into amino acid sequences using Expasy translate tool.
These protein sequences were then used to predict CD8+ T cell
epitopes using CTLPred software [20]. A similar strategy was used
to predict CD8+ T cell epitopes in sequences from Kenyan,
Pakistani and Afghan cohorts. Additionally, for sequences from
our study cohorts, the MHC restriction for each epitope was
predicted using ProPred-I [21] and nHLAPred software [22].
Since HLA data was available for our three study cohorts,
population and allele frequencies of HLA for these cohorts were
calculated using online HLA frequency tool available at Los
Alamos website (Los Alamos National Laboratory, http://www.
hiv.lanl.gov). This tool computes the 2-sided exact Fisher’s p-value
for each HLA in a given population. False discovery was corrected
by Storey’s q-value. HLA alleles were represented in the Kenyan,
Afghan and Pakistani cohorts with a frequency of 10% or above
were marked as ‘predominant HLA alleles’ in the three cohorts.
Sequences from our three study cohorts were part of 2005–2010
year-group, when analysis for genetic variability (i.e., GRA
substitutions and Shannon entropy) and epitope prediction was
carried out. To confirm whether observations for genetic
variability and immunodynamics analysis were also reflected in a
population-specific manner, sequences from these three cohorts
were also analysed separately.
Results
Analysis of the phylogenetic relationships, origin, and
global epidemic dynamics of HIV-1 subtype A
Phylogenetic relationships among the HIV subtype A gag
sequences were inferred through a Maximum Likelihood (ML)
tree. For this analysis, an SIVcpz gag sequence was used as an
outgroup to root the ML tree. Analysis of the tree structure
revealed that HIV-1 subtype A gag sequences from the different
year-groups were scattered throughout the phylogenetic tree,
without any apparent relationship between branching topology
and time of sampling (Figure 1). There are significant clusters in
the tree supported by bootstrap values greater than 70%.
However, since 90% of the sequences in the tree are from Kenya,
these clusters likely represent some Kenya transmission networks.
However, there was one significant cluster in the tree that was
comprised of sequences from just Pakistan and Afghanistan
(Figure 1, green shaded square).
To explore the relationship between gag divergence and
epidemic dynamics, Bayesian Skyline analysis was performed.
Using this analysis, the most recent common ancestor (tMRCA) of
HIV-1 subtype A was estimated to be around 195661 (Figure 2,
black dotted line). Compared to the origin of tMRCA, the
Bayesian Skyline plot identified at least an initial 10-fold growth in
viral effective population size (correlating with effective number of
infections and/or transmission opportunities [23]) during the early
to mid-1980s (Figure 2, red area). Effective population size became
stationary from the mid-to-late 1980s until the early 2000s
(Figure 2, blue area), followed by a period of decline, where an
approximate 3-fold decrease was observed (Figure 2, green area).
The effective population size became stationary from about 2004
onwards. Sequences with high GRA substitutions can introduce
bias in the Skyline analysis by introducing noise in the overall data.
To control for the effect of high GRA substitutions on the overall
effective population size and tMRCA, in a separate analysis all
sequences with high GRA substitutions were removed and
Bayesian analysis was performed again. The resulting Skyline
plots, and tMRCA were found to be similar to the one where
sequences with high GRA substitutions were retained in the
analysis (data not shown).
Time-dependent genetic evolution of HIV subtype A gag
In order to analyse HIV-1 subtype A gag variability over the
study period, we performed GRA substitutions and Shannon
entropy analysis on subtype A gag sequences grouped into five 5-
year sets. It was observed that during the first ten years of the
epidemic (1985–1995), GRA substitutions were at a low level with
a mean of about two substitutions per sequence (Figure 3a)., A
significant (p,0.001) increase in GRA substitutions was observed
from 1995 though 2000 compared to the earlier time-periods,
which continued into the last five years (2005–2010) of epidemic
(Figure 3a). Shannon entropy analysis revealed a significant (p,
0.001) increase in entropy from years 1985–90 to 1990–95
(Figure 3b, Figure 3b insert), followed by a plateau phase until
2005, when the change in entropy was non-significant. Compared
to all other year-groups, the last six years (2005–10) were marked
by a sharp, significant (p,0.001) increase in entropy (Figure 3b,
Figure 3b inset). It was interesting to note that this increase in
entropy was most profound in the p2p7p1p6 region of HIV-1 gag
(Figure 3b, blue peaks).
Time-dependent global immunodynamics of HIV-1
subtype A gag
To analyse the diversity of gag epitopes over time, the number
of CTL epitopes, their HLA restriction and epitope variability
(total number of mutations in all epitope sequences in a given year-
group/total number of epitopes in a year-group) were evaluated
over the years 1985–2010.
Consistent with GRA substitution and Shannon entropy
analyses, a time-dependent increase in the diversity of gag epitopes
was observed. Only three unique epitopes were observed during
1985–1989 (Figure 4 and Figure S1, red highlighted epitopes),
while only one was observed in 1990–94 (Figure 4 and Figure S1,
blue highlighted epitopes). This was followed by 10 years (1995–
2004) where no novel epitopes and only negligible epitope
variability was observed. During the last six years of the study
period (2005–2010), the highest number (12) of unique epitopes
was observed (Figure 4 and Figure S1, green highlighted epitopes).
Similarly, in the same year-group, the highest increase in epitope
variability (33%) was observed, compared to the rest of the study
periods.
Population-specific immunodynamics of HIV-1 subtype A
gag
To confirm whether genetic variability observations in the
preceding analysis were also reflected in a population-specific
manner, we analysed HIV-1 subtype A gag variability and gag
epitope data from the Kenyan, Pakistani, and Afghan cohorts that
we have been studying for the past five years [4,8,9,24,25].
Sequences from these three cohorts are predominantly found in
2005–2010 year-group.
It was observed that these Kenyan sequences had significantly
higher Shannon entropy (p,0.001) as compared to Pakistani and
Afghan sequences (Figure 5a, bar graphs). GRA substitutions
analysis revealed that Pakistani and Afghan sequences had a
slightly higher number of GRA substitutions as compared to
Kenyan sequences, however, the difference was not significant
(Figure 5a, scatter plot).
To analyse the diversity of gag epitopes in the three cohorts, the
number of CTL epitopes, their HLA restriction profile, and
epitope variability (total number of mutations in all epitope
HIV-1 Subtype A Epitope Evolution
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sequences in a given cohort/total number of epitopes in a cohort)
was evaluated. In Pakistani, Afghan, and Kenyan cohorts,
respectively, 10, 10, and 11 unique gag epitopes were observed
(Figure 5c). The repertoire of epitopes was identical between
Pakistani and Afghan cohort, while distinct from those in the
Kenyan cohort (Figure 5c). Since a major portion of the HIV
sequences from the Pakistani and Afghan cohorts are phylogenet-
ically closely linked (Figure 1), observing a high degree of similarity
in their epitope pattern was not surprising. Furthermore, since
sequences in the 2005–2010-year group were predominantly from
Figure 1. Maximum likelihood (ML) tree of HIV-1 subtype A gag gene sequences. ML tree was used to infer phylogenetic relationship
among the 1,893 HIV-1 subtype A gag sequences submitted to the LANL HIV Sequence Database, representing the years 1985 to 2010. Grey shaded
area shows the outgroup sequence SIVcpz gag, that was also used to root the tree. Sequences from year-groups 1985–1990, 1990–1995, 1995–2000,
2000–2005, and 2005–2010 are shown in red, blue, orange, pink and green colour, respectively. The Green shaded area indicates sequences from
Afghanistan and Pakistan that were found to group together. The green boxes indicate position and number of Afghan (AFG) and Pakistani (PK)
sequences present in the tree. Nodes with bootstrap values .90, .80 and .70 are indicated by red, green and orange circles, respectively.
doi:10.1371/journal.pone.0093415.g001
HIV-1 Subtype A Epitope Evolution
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these three cohorts, the epitope profile of this year-group
considerably overlapped with that of the three cohorts (compare
Figure 5c and Figure S1).
The HLA restriction pattern predicted for the gag epitopes from
Afghan, Kenyan and Pakistani cohorts revealed cohort-specific
differences in HLA restriction profiles, which were identical in
Afghan and Pakistani cohorts, but distinct in Kenyan cohort
(Figure 5c; grey highlighted rows).
Discussion
In this study, using all 1,893 sequences from the HIV-1 subtype
A gag p24 and p2p7p1p6 region submitted to the LANL HIV
Sequence Database, representing 19 countries and years 1985
through 2010, we examined the time-dependent evolution of HIV-
1 subtype A. Out of these sequences, 94 were from our Afghan,
Kenyan and Pakistani cohorts, and we used these sequences to
perform population-specific immunodynamics of HIV-1 subtype A
gag gene region. Our analysis was specifically focused on the
genetic variability and epitope diversity in this gene region.
Phylogenetic analysis revealed that HIV-1 subtype A gag
sequences from different year-groups were dispersed throughout
the tree suggesting on-going evolution or diversification of the
virus throughout the epidemic [6]. While we identified dispersed,
significant clusters of sequences throughout the tree, most of the
sequences (about 90%) in our analysis were from Kenya – which
most likely skewed the overall phylogeny to reflect Kenyan
transmission clusters. We also found that the majority of sequences
from Afghanistan and Pakistan (year group 2005–10), grouped
together in a single monophyletic cluster (Figure 1, green
highlight). Clustering of Afghan and Pakistani sequences reflects
the close relationship between the subtype A epidemic in the two
countries, as evident from our previously published data [4,26].
The HIV strains in Afghan refugees and Pakistani HIV-infected
communities share phylogenetic relationship most likely because
the routes of transmission of infection are the same between
Pakistani patients and the Afghan refugees residing in Pakistan
[4,26].
Bayesian analysis indicated that the most recent common
ancestor of what we call HIV-1 subtype A viruses arose about
1956. Based on effective population size, from 1956 until about
1980, there was a low and stable level (effective population size:
16101.5) of HIV transmissions. Beginning in 1980, there was a
rapid, epidemic-level expansion of HIV-infections which peaked
about 1987 [23]. Following by a stationary phase or stabilization
of the epidemic that lasted until early 2000, followed by a short
period of decline until about 2004, after which the epidemic began
to plateau once again.
HIV gag genetic variability (measured using GRA substitutions
and entropy) during the first 10 years (1985–95) of the epidemic
increased significantly (p,0.001) from the mid-1990s onwards,
eventually reaching a peak between 2000–2010. This trend was
also observed for subtype A gag epitope patterns where novel
epitopes and epitope mutations reached a peak between 2005–
2010.
Following HIV-1 infection, the host immune system strives to
control the viral load, while the virus struggles to escape the host
defence by incorporating immune escape mutations into its
genome, driven by selection pressures, resulting in increased
variability in the viral genome [27]. The parameters for measuring
Figure 2. HIV-1 subtype A effective population size and time for most recent common ancestor. Bayesian Skyline plot, based on a
‘relaxed clock’ coalescent framework analysis, was constructed using 113 sequences (representing all years and countries). X-axis represents time in
years, while Y-axis shows the effective population size. The thick black line represents the median, while the blue band represents 95% highest
posterior density (HPD) intervals. The tMRCA of HIV-1 subtype A is indicated by a black dotted line and red box, while the time for the 1985 sequence,
which was the oldest reported HIV subtype A strain in the LANL Sequence Database) is indicated by a red arrow. Red, light blue and green shaded
areas represent the period of increase in viral effective population size, plateau phase, and decline, respectively.
doi:10.1371/journal.pone.0093415.g002
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genetic variability used in this study were Shannon entropy and
GRA substitutions. Shannon entropy is a measure of the
probability of acquiring mutations, including epitope-related
mutations, in a given set of genomic sequences [27]. On the
other hand, GRA substitutions, introduced into the viral genome
by the host’s secondary viral control factors, such as APOBEC
protein [27], also contribute to the genetic variability of the virus
[28].
Evaluation of epidemic dynamics and genetic variability helps in
determining the course of viral evolution. The decrease observed
in viral effective population size after 2004, combined with an
increase in gag gene and epitope variability from 2005 onwards
might be reflective of subtype A strains in populations with
immunogenetic backgrounds that may increase the amount of
immunological escape mutations while negatively affecting viral
replication fitness [29]. For instance, it may be an indication of the
introduction of subtype A viruses in populations having a
predominance of protective alleles, such as HLA B*51 [30], as
observed in the Afghan and Pakistani populations we studied
[4,5,24,25], where HLA data was available. The observed
variability in the gag gene, as well as in the epitope pattern,
could be driven, in part, by the varying HLA backdrops the viruses
encountered as the HIV epidemic travelled through different
populations. In addition, continuing HIV evolution over time, as
well as founder effects arising from the introduction of new, unique
subtype A strains within a population, also contribute to diversity
in gag. This was especially apparent in our three cohort analysis
(Figures 5a and 5b). For example, epitope LGAGATLEE,
observed in Kenyan cohort, was predicted to be restricted by
HLA A*24/C*04/B*27. This epitope was mutated to LGTGA-
TLEE in Pakistani and Afghan cohorts, changing the predicted
restriction to HLA A*68 (Figure 5c, grey highlighted rows).
A relatively high value of sequence entropy and epitope
variation observed in Pakistani, Afghan and Kenyan sequences
in the years 2005–2010 may indicate a transient phase in the virus’
genetic evolution, which may later be followed by a refinement
and amplification of discreet escape mutants, which is probably
indicated by the stabilization in viral effective population size
observed from about 2004 onwards. Keeping in mind the limited
number of sequences available from 2004-onwards, it is likely that
this analysis represents an incomplete picture of the status of
epidemic from 2004 onwards. As more subtype A sequences from
this period become available, similar analyses will give a better
insight into how the genetic and immunological pressures will
shape the HIV epidemics in the upcoming years.
A year-wise analysis of epitope sequences from the same
populations will help in deciphering the true nature of this
phenomenon. Further analyses will provide a better understanding
of the directions in which the HIV-1 epidemics continue to evolve.
This information will be crucial in anticipating prevention and
control strategies for subtype A-infected patients, especially in
populations where the epidemic is newly emerging.
Figure 3. Time-dependent changes in HIV-1 subtype A genomic variability. HIV-1 gag variability was measured for all five year-groups
using a) GRA substitutions and b) Shannon entropy. a) GRA substitutions: Small black circles represent number of substitutions for each sequence;
grey lines show the mean for a particular year-group. The red line over the scatter plot represents statistically significant (p,0.001) differences
between groups. b) Shannon entropy analysis: The vertical axis represents entropy scores, while the horizontal axis shows position of amino acids in
the gag gene. Shannon entropy scores for each year-group are represented in the following colors: 1985–90 (turquoise), 1990–95 (purple), 1995–00
(green), 2000–05 (red) and 2005–2010 (blue) Insert: Mean entropy score for each year-group was calculated and plotted using GraphPad software.
Red line over bars represents a statistically significant difference between the groups (p,0.001). Error bars represent the standard error of the mean.
doi:10.1371/journal.pone.0093415.g003
Figure 4. Divergence and evolution of HIV-1 subtype A gag epitopes. Bar chart summarizing epitope data for each year-group. Black bars
show the total number of gag epitopes observed for each year-group, white bars represent epitope variability (total number of mutations in all
epitope sequence in year-group/total number of epitopes in a year-group), and grey bars indicate novel epitopes that were observed for each year-
group.
doi:10.1371/journal.pone.0093415.g004
HIV-1 Subtype A Epitope Evolution
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Supporting Information
Table S1 Sequences used in this study. A total of 1893
sequences were used in the study. The table represents, for each
year-group: total number of sequences, countries from where the
sequences were deposited and number of sequences from each
country. Sequences from our Kenyan, Pakistani and Afghan
cohorts are shaded grey.
(DOCX)
Figure S1 Time-dependent evolution of HIV-1 subtype A
gag epitopes. All epitopes were identified in the HIV-1 subtype
Figure 5. Cohort-specific analysis of HIV-1 subtype A gag gene and epitope variability. A) Genomic variability was measured for
sequences from our Afghan, Pakistani and Kenyan cohorts using A) GRA substitutions and Shannon entropy. GRA substitutions (right): Small black
circles represent the number of substitutions for each sequence, while the grey lines show the mean for a particular cohort. Shannon entropy analysis
(left): A single star over bars represents a statistically significant (p,0.001) difference between the groups. The red bars represent standard error of
mean. B) Bar chart summarizing the epitope data for Kenyan, Pakistani and Afghan study cohorts. Black bars show the total number of gag epitopes
observed for each cohort, white bars represent epitope variability (total number of mutations in all epitope sequence in cohort/total number of
epitopes in a cohorts), and the grey bars show the unique epitopes observed for each year-group, C) All epitopes and their corresponding predicted
HLA restriction patterns that were identified in HIV-1 subtype A gag sequences for the three study cohorts. Epitopes observed in Pakistan and Afghan
cohorts are highlighted red, while epitopes specific to Kenyan cohort are highlighted blue. Red letters denote mutations observed in a particular
epitope, while the grey highlighted rows represent epitopes for which loss or gain of HLA restriction pattern was observed. HLA highlighted in bold
indicate alleles that were predominantly observed in the study cohorts (see Methods).
doi:10.1371/journal.pone.0093415.g005
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A gag sequences for each year-group (columns 1–5), and epitopes
found to be unique in each year-group are highlighted: 1985–90
(red), 1990–95 (blue) and 2005–2010 (green). Red letters denote
mutations observed in a particular epitope when compared with
similar epitopes in other year-groups.
(DOCX)
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